Hybrid therapy tops for H. pylori infectionTwo-week combined strategy achieves superior eradication rates New protease inhibitor showing promise for hepatitis CEarly study suggests experimental drug telaprevir offers option for patients who have not responded to standard treatment How much do adverse events cost? Focused research to determine economics of patient safety Three of 5 nurses in Florida are leaving the state's work force Sponge-derived drug extends breast cancer survival Elderly lung cancer patients benefit from aggressive chemo 'Remarkable' four-month improvement in survival will change practice, researchers say Frontline care driving antimicrobial resistance problem ER closure-rate identified Full-face transplant? Anxiety responds to flexible treatment First Previous 394 395 396 397 398 Next Last
